Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Sales | 608 | 0 | 3,000 | 0 | 0 |
| Cost of Goods | 353 | 0 | N/A | N/A | N/A |
| Gross Profit | 255 | 0 | 3,000 | N/A | N/A |
| Operating Expenses | 12,767 | 5,160 | 3,847 | 3,597 | 0 |
| Operating Income | -12,160 | -5,160 | -847 | -3,597 | N/A |
| Interest Expense | 0 | 4,130 | 2,860 | 2,866 | 0 |
| Other Income | -3,749 | -3,948 | 0 | -19 | 0 |
| Pre-tax Income | -15,909 | -13,238 | -3,707 | -6,482 | 0 |
| Net Income Continuous | -15,909 | -13,238 | -3,707 | -6,482 | N/A |
| Net Income | $-15,909 | $-13,238 | $-3,707 | $-6,482 | $N/A |
| EPS Basic Total Ops | -126.69 | -781.11 | -518.74 | -934.03 | N/A |
| EPS Basic Continuous Ops | -126.52 | -781.36 | -518.48 | -934.42 | N/A |
| EPS Diluted Total Ops | -126.69 | -781.11 | -518.74 | -934.03 | N/A |
| EPS Diluted Continuous Ops | -126.52 | -781.36 | -518.48 | -934.42 | N/A |
| EBITDA(a) | $-12,052 | $-5,131 | $-805 | $-3,553 | $N/A |